Sun, Feb 1, 2015, 4:15 AM EST - U.S. Markets closed

Recent

% | $
Quotes you view appear here for quick access.

Amarin Corporation plc Message Board

kot882001 2 posts  |  Last Activity: Nov 1, 2014 3:21 PM Member since: Sep 26, 2010
SortNewest  |  Oldest  |  Highest Rated Expand all messages
  • kot882001 kot882001 Nov 1, 2014 3:21 PM Flag

    I can also speculate that if it were some bad news, AM would try in person sugar coating it....

  • Reply to

    MARK MY WORDS ON SNO results for RINDO

    by werr999 Oct 31, 2014 11:00 PM
    kot882001 kot882001 Nov 1, 2014 12:49 PM Flag

    While I'm less sure that management will try to get FDA approval for Avastin refractory patients simply because AM usually takes more secured even more lenghty path to approval, I also think that Rindo will show statistically significant improvement in PFS, but while it will be improvement in OS, it probably won't be statistical one.
    I also think that even if we see somewhat positive results the s/p will go down up to 15%, but will recover by quarterly CC or SNO.
    Of course if we see OS & PFS statistically significant we'll see $20+ or even $30+.
    I'm leaving today for Maynmar, no internet most of the time, come back on 11/20 and will see what actually happened.
    I also don't believe that we'll see $9. The worst case scenario is $13. (This believe based on fact this forum is more fit to report at least somewhat positive developments and not outright failure.
    It is also possible that while patients were relapsed & refractory Avastin, the combination with Rindo very well could produce better effect then each one of them separately....)

AMRN
1.02-0.01(-0.97%)Jan 30 4:00 PMEST

Trending Tickers

i
Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.